Atlas Trials

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Clinical trial NCT03244072 · NOT_YET_RECRUITING

Trial details

NCT number
NCT03244072
Sponsor
Jason Ahee, M.D.
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Endophthalmitis
Start date
2026-06-01
Primary completion
2030-10-01
Enrollment
60000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.